临床外科杂志 ›› 2021, Vol. 29 ›› Issue (8): 722-725.doi: 10.3969/j.issn.1005-6483.2021.08.008

• • 上一篇    下一篇

微波消融治疗晚期肺腺癌临床分析

  

  1. 安徽省合肥市第二人民医院胸心外科
  • 出版日期:2021-08-20 发布日期:2021-08-20

Clinical study of microwave ablation in the treatment of advanced lung adenocarcinoma

  • Online:2021-08-20 Published:2021-08-20

摘要: 目的;观察微波消融治疗对晚期肺腺癌病人免疫炎性反应及预后的影响。方法:2016年2月~2019年2月我院收治的驱动基因阴性的晚期肺腺癌病人86例,按随机数字表法分为微波消融组和对照组,每组各43例。对照组接受吉西他滨+卡铂化疗,微波消融组接受吉西他滨+卡铂+微波消融治疗。观察两组病人治疗前后应激指标、炎症指标、免疫指标变化情况及近期疗效。对病人进行随访(随访至2020年4月),观察两组病人生存情况。结果:微波消融组客观缓解率(58.14%)和疾病控制率(83.71%)高于对照组(34.88%、65.12%),差异有统计学意义P<0.05)。治疗4周后微波消融组丙二醛为(135.1±11.0)mg/L、超氧化物歧化酶为(5.4±2.2)U/L、C反应蛋白为(8.3±2.5)mg/L、白细胞介素6为(76.9±7.1)pg/ml、降钙素原为(5.9±1.5)ng/ml,对照组分别为(129.6±10.9)mg/L、(5.2±2.0)U/L、(8.6±2.9)mg/L、(75.8±8.9)pg/ml、(5.1±2.0)ng/ml,两组比较差异无统计学意义(P>0.05),治疗后微波消融组CD8+为(44.9±5.1)%、CD4+/CD8+为(1.49±0.58),对照组分别为(30.8±4.9)%、(1.31±0.52),两组比较差异有统计学意义(P<0.05)。随访时间13~48个月,平均随访时间为(29.4±4.9)个月,成功随访率为94.2%,KaplanMeier法并对数秩检验显示,微波消融组累积生存率高于对照组,差异有统计学意义(P<0.05)。结论:微波消融治疗可显著改善晚期肺腺癌近期疗效及生存情况,安全性高,不影响应激反应和炎症反应,且可改善免疫功能。

关键词: 微波消融, 晚期肺腺癌, 炎症反应, 应激反应, 免疫功能

Abstract: Objective:To observe the effect of microwave ablation on immune inflammatory response and prognosis in patients with advanced lung adenocarcinoma.Methods:A total of 86 driver genenegative patients with advanced lung adenocarcinoma who were admitted to Hefei Second People's Hospital from February 2016 to February 2019 were selected and divided into a microwave ablation group and a control group according to the random number table method,43 cases each.The control group received gemcitabine + carboplatin chemotherapy,and microwave ablation treatment was added to the microwave ablation group.The changes of stress indexes,inflammation indexes,immune indexes and shortterm efficacy in both groups were observed.The patients were followed up to April 2020 to observe the survival of the two groups of patients.Results:The objective response rate(58.14%) and disease control rate(83.71%) of the microwave ablation group were higher than those of the control group(34.88%,65.12%,P<0.05).After 4 weeks of treatment,the microwave ablation group MDA[(135.1±11.0)mg/L],SOD[(5.4±2.2)U/L],CRP[(8.3±2.5)mg/L],IL6[(76.9± 7.1)pg/ml],PCT[(5.9±1.5)ng/ml] were not statistically different from the control group[(129.6±10.9)mg/L,(5.2±2.0)U/L,(8.6±2.9) mg/L,(75.8±8.9)pg/ml,(5.1±2.0)ng/ml,P>0.05],CD4+[(44.9±5.1)%],CD4+/CD8+(1.49±0.58) in microwave ablation group after treatment were higher than the control group[(30.8±4.9)%,(1.31±0.52),P<0.05].The followup time was 1348 months.The average followup time was(29.4±4.9) months.The successful followup rate was 94.2%.The KaplanMeier method and log rank test showed that the cumulative survival rate of the microwave ablation group was higher than that of the control group(P<0.05).Conclusion:Microwave ablation therapy can significantly improve the shortterm efficacy and survival of advanced lung adenocarcinoma.It has high safet,improve immune function and does not affect the stress response.

Key words: microwave ablation, advanced lung adenocarcinoma, inflammatory response, stress response, immune function

[1] 杨晓光, 苏鹏, 陈海洋. 全腔镜Ivor-Lewis术对食管癌根治术病人应激反应及胃肠功能的影响[J]. 临床外科杂志, 2021, 29(8): 726-729.
[2] 周麟, 潘华锋, 李琰. 超声引导下经皮微波消融与无水酒精注射微创治疗囊实性良性甲状腺结节的临床疗效对比分析[J]. 临床外科杂志, 2021, 29(6): 517-520.
[3] 彭启旺 邓浩. 肠内营养支持对根治性胃癌术后胃肠功能、营养状态和应激炎性反应影响[J]. 临床外科杂志, 2021, 29(5): 445-448.
[4] 李光远 刘正 吴长山 岳培东 郭志强. 经皮穿刺微球囊压迫术在老年原发性三叉神经痛病人中的应用[J]. 临床外科杂志, 2021, 29(5): 488-491.
[5] 陈宇, 方汉林, 刘闻. 全胸腔镜手术对肺癌病人的肿瘤标志物神经元特异烯醇化酶、降钙素原、CD3+、CD4+和CD8+的影响[J]. 临床外科杂志, 2021, 29(2): 140-142.
[6] 周超 李文涛 王瑞 方文涛. 双镜联合治疗同时性多原发肺癌13例临床分析[J]. 临床外科杂志, 2021, 29(1): 38-41.
[7] 刘苹 吴茜 王思桦 姚尚龙. 超声引导下前锯肌平面阻滞对保留自主呼吸的胸腔镜手术术后镇痛及应激反应的影响[J]. 临床外科杂志, 2020, 28(8): 784-786.
[8] 张涛 郑明友 黄书明 陈圣开 李剑波 商阳阳. 加速康复外科对腹腔镜胆总管探查一期缝合病人康复及应激的影响[J]. 临床外科杂志, 2020, 28(7): 669-672.
[9] 李安 秦大磊. 左胸单切口与右胸腹双切口在胸中下段食管癌手术中的应用比较[J]. 临床外科杂志, 2020, 28(7): 693-695.
[10] 狄子杨, 唐强, 狄茂军等. 腹腔热灌注化疗治疗晚期结直肠癌的疗效分析[J]. 临床外科杂志, 2020, 28(5): 433-436.
[11] 姚晶 李鸿 夏东. 术前系统性炎症反应指数对胆囊癌病人预后的影响[J]. 临床外科杂志, 2020, 28(10): 962-965.
[12] 施飞, 施柳辉, 石博文, 唐海啸, 黄云腾. 羧甲基壳聚糖冲洗液预防输尿管软镜碎石术后感染性并发症发生的临床研究[J]. 临床外科杂志, 2019, 27(8): 689-692.
[13] 李维, 黄永超. 经皮微创内固定联合术后唑来膦酸治疗胸腰椎骨折的疗效及对T细胞亚群的影响[J]. 临床外科杂志, 2019, 27(4): 345-348.
[14] 方红, 赵子伟, 韩雪, 姚永强. 麦默通微创旋切术切除直径1cm良性乳腺肿块的临床疗效及其对病人免疫功能的影响[J]. 临床外科杂志, 2019, 27(3): 205-208.
[15] 疏楠, 方原, 汪洋. 经腹与经胸贲门癌根治术对高龄贲门癌病人疗效及免疫功能的影响[J]. 临床外科杂志, 2019, 27(2): 170-172.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 魏征, 胡仁旺. 肝脏多发血管瘤术前诊断为肝胆管囊腺癌一例[J]. 临床外科杂志, 2019, 27(2): 124 -125 .
[2] 屈日荣, 田义涛, 别磊, 张洋, 付向宁 . 心包内异位甲状腺一例[J]. 临床外科杂志, 2019, 27(11): 959 -960 .
[3] 勾善淼, 吴河水. 胰头癌腹腔镜切除的现状及展望[J]. 临床外科杂志, 2019, 27(12): 1091 -1093 .
[4] 谢毅 叶哲伟. 区块链技术的医学应用现状与前景[J]. 临床外科杂志, 2020, 28(4): 304 -307 .
[5] 胡丽娟, 戴奇山, 胡建波. 前列腺癌骨转移病人唑来膦酸不同给药间期疗效比较[J]. 临床外科杂志, 2020, 28(5): 472 -475 .
[6] 韩同磊, 赵志青. 经颈动脉血运重建术对颈动脉狭窄治疗方式的挑战[J]. 临床外科杂志, 2020, 28(6): 508 -510 .
[7] 李永康, 王南鹏, 杨能红. 左颈清术后合并双侧乳糜胸及肺炎一例[J]. 临床外科杂志, 2020, 28(6): 598 .
[8] 彭丰 王敏 谢昱 秦仁义. 长链非编码RNA SNHG1在胆管癌中的表达与临床特征及预后的相关性分析[J]. 临床外科杂志, 2020, 28(8): 725 -727 .
[9] 任宇 王刚乐. 麦默通旋切术用于乳腺癌病灶切除的临床价值[J]. 临床外科杂志, 2020, 28(8): 764 -766 .
[10] 李明博, 李卫民, 殷强等. Amyand疝一例[J]. 临床外科杂志, 2020, 28(11): 1073 -1074 .